Piyasa Haberleri

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y

Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.

İlgili Semboller 1

R RMD RMD

Kaynak: Zacks Investment Research

0 0 0

Kaynak: New York Post Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Sweetgreen falls 10% as latest victim of cyclospora fears, removes jalapeños over second outbreak

For the second quarter ending June 28, Sweetgreen's same-store sales fell 6.2% – its sixth straight decline.

İlgili Semboller 1

S SG SG

Kaynak: New York Post

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Why Imperial Oil Cut Refinery Guidance 6% Despite Strong Q2 Results

Imperial Oil's stronger Q2 earnings contrast with lower 2026 refinery targets, putting the focus on a second-half volume recovery.

İlgili Semboller 1

I IMO IMO

Kaynak: Zacks Investment Research

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

SPCX Fell 24.5% in the Past Month: Is the Sell-Off an Opportunity?

SPCX's 24.5% monthly slide contrasts with surging revenues, profitable Starlink growth and fast AI gains, while valuation and spending keep risks high.

İlgili Semboller 1

S SPCX SPCX

Kaynak: Zacks Investment Research

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

SpaceX's $6.7B Cloud Deal Could Reshape Its Near-Term AI Economics

SPCX's $6.7B cloud deal boosts near-term AI revenue visibility, but heavy capex, concentration and reported AI losses keep economics mixed.

İlgili Semboller 1

S SPCX SPCX

Kaynak: Zacks Investment Research

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Should You Buy, Sell or Hold SMCI Stock Before Q4 Earnings?

Super Micro Computer heads into Q4 fiscal 2026 earnings with AI infrastructure demand, delayed deployment conversions and margin pressure in focus.

İlgili Semboller 1

S SMCI SMCI

Kaynak: Zacks Investment Research

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Somnigroup Q2 Earnings Meet, Sales Miss on Mattress Firm Decline

SGI's Q2 margins and cash flow improve on synergy gains, but weaker sales and a lower 2026 earnings outlook temper the results.

İlgili Semboller 1

S SGI SGI

Kaynak: Zacks Investment Research

0 0 0

Kaynak: Newsfile Corp Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Kaplan Fox Encourages Investors of Cerebras Systems Inc. (CBRS) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cerebras Systems Inc. ("Cerebras" or the "Company") (NASDAQ: CBRS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Cerebras investor and have suffered losses, or if you have information that could assist in the Cerebras investigation, you may CLICK HERE to contact us.

İlgili Semboller 1

F FOX FOX

Kaynak: Newsfile Corp

0 0 0

Kaynak: GlobeNewsWire Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Kaplan Fox Urges EquipmentShare.Com Inc (NASDAQ: EQPT) Investors to Contact the Firm Before the Deadline on September 21, 2026

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against EquipmentShare.Com Inc (“EquipmentShare” or the “Company”) (NASDAQ: EQPT) on behalf of investors who purchased or otherwise acquired EquipmentShare common stock pursuant and/or traceable to the Company's initial public offering on or around January 23, 2026 (the “IPO”), or between January 23, 2026 and June 23, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in EquipmentShare and have suffered losses, you may CLICK HERE to contact us.

İlgili Semboller 1

E EQPT EQPT

Kaynak: GlobeNewsWire

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

Moderna Q2 Earnings Call Highlights Cost Cuts and Pipeline Milestones

MRNA keeps its 2026 growth target intact while cutting cost guidance and advancing flu, oncology and rare-disease programs toward key milestones.

İlgili Semboller 1

M MRNA MRNA

Kaynak: Zacks Investment Research

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

CINF Outperforms Industry: What Should Investors Do Now?

Cincinnati Financial's disciplined underwriting, agency-led growth and rising investment income support long-term growth despite catastrophe risks.

İlgili Semboller 1

C CINF CINF

Kaynak: Zacks Investment Research

0 0 0

Kaynak: 24/7 Wall Street Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

SpaceX Rises 11%, Intuitive Machines Gains 9%, Rocket Lab Jumps 8% as Wall Street Gives the All-Clear on Space Stocks

Space stocks are rallying across the board in midday Friday trading, with SpaceX (NASDAQ:SPCX | SPCX Price Prediction) shares leading the group.

İlgili Semboller 1

L LUNR LUNR

Kaynak: 24/7 Wall Street

0 0 0

Kaynak: Zacks Investment Research Haber Ajansı

1 ay önce

Hisse Senedi Orta Önem

ETFs to Buy as AMD Shares Sink 7% Despite Q2 Earnings Beat

AMD slides after beating Q2 estimates, but strong AI and data center growth outlooks may steer investors toward ETFs with meaningful exposure to this chipmaker.

İlgili Semboller 1

A AMD AMD

Kaynak: Zacks Investment Research

0 0 0